Hong Kong doctor spared jail for fraudulently obtaining cough syrup, ADHD drugs

A former consultant doctor in Hong Kong has been sentenced to community service and fined after being found guilty of misusing hospital resources by fraudulently obtaining cough syrup and ADHD medications. The decision came on Thursday as the District Court handed down its ruling on Lee Chi-leung, an ear, nose and throat specialist who served as an associate consultant at Queen Elizabeth Hospital. Lee, aged 51, was convicted of two counts of misconduct in public office. The court imposed a 160-hour community service order and required him to pay HK$20,000 (approximately US$2,550) in compensation to the Hospital Authority. His crimes spanned from March 2015 to September 2020, during which time he allegedly abused his position to acquire over 1,000 bottles of cough syrup and more than 400 tablets of ADHD medication. According to the Independent Commission Against Corruption, Lee orchestrated a scheme involving the use of the names of six family members and two domestic helpers to create fictitious medical appointments. Through this method, he was able to issue false prescriptions under these names, thereby misappropriating the prescribed medications for personal use. Additionally, Lee was found to have given excessive quantities of cough syrup to two other patients, instructing them to return the excess for his own benefit. The court heard that Lee's actions were motivated by personal gain, with the judge noting that he had misused hospital resources to fulfill his own needs. The judge, Josiah Lam Wai-kuen, emphasized that the improper prescription records could have compromised the accuracy of drug dosages for Lee’s previous patients, potentially affecting their treatment outcomes. The case highlights the potential for abuse within healthcare systems, particularly when individuals in positions of trust exploit their roles for personal advantage. The sentencing reflects the legal system’s response to such misconduct, balancing punitive measures with rehabilitative efforts through community service. The incident underscores the importance of stringent oversight and accountability mechanisms in public health institutions. It also raises questions about the adequacy of current protocols in preventing similar abuses. While the court has taken action against Lee, the broader implications for institutional integrity remain a subject of ongoing scrutiny. As the legal proceedings conclude, the focus shifts to ensuring that such incidents do not recur. The Hospital Authority and regulatory bodies will likely review internal procedures to enhance transparency and prevent future occurrences of fraudulent behavior by medical professionals. The case serves as a cautionary tale, reinforcing the need for vigilance and ethical conduct in the medical field.